1. Home
  2. Procedures & Services
  3. Thyroid Eye Disease & Orbital Decompression Surgery

Thyroid Eye Disease & Orbital Decompression Surgery

Thyroid eye disease is an autoimmune condition in which abnormal immune activity causes swelling of the tissues around the eyes and forward displacement of the eyeballs. It is commonly associated with hyperthyroidism, such as Graves' disease. Orbital decompression surgery is a procedure performed for patients with thyroid eye disease. By removing orbital fat or portions of the orbital bone wall, the surgery reduces intraorbital pressure, helping to improve eye protrusion, vision impairment, and related ocular discomfort.

What Is Thyroid Eye Disease?

Thyroid eye disease, medically known as Graves' ophthalmopathy, affects both the appearance and the function of the eyes. It is a complex autoimmune inflammatory disorder commonly associated with hyperthyroidism—particularly Graves' disease—although it may sometimes occur independently or even develop in patients with completely normal thyroid function.
In thyroid eye disease, the immune system mistakenly attacks healthy tissues deep within the orbit, including the muscles that control eye movement and the orbital fat. This triggers inflammation and tissue enlargement, which can lead to eye protrusion (proptosis), double vision (diplopia), eyelid retraction, and other distressing symptoms. These manifestations not only impact daily quality of life and self-confidence, but in severe cases, may pose a serious and irreversible threat to vision.

Causes of Thyroid Eye Disease

The core mechanism of thyroid eye disease is a misdirected autoimmune attack. The immune system mistakenly identifies the tissues behind the eyes as "foreign invaders" and launches an attack. The targeted tissues—including the extraocular muscles that control eye movement and the orbital fat—become inflamed, swollen, and may eventually undergo fibrosis. Although the exact trigger remains under investigation, it is widely believed that thyroid-stimulating hormone receptor antibodies (TSHR antibodies)—commonly elevated in hyperthyroidism such as Graves' disease—play a major role. These antibodies not only act on the thyroid gland but also affect orbital tissues, leading to inflammation and tissue expansion.

Major Risk Factors

Sex and Age

Thyroid eye disease most commonly affects women between the ages of 30 and 50, with females showing a significantly higher incidence than males. However, among patients with more severe disease, men over 50 years old represent a disproportionately higher percentage.

Smoking

Smoking is the strongest known risk factor. It increases the likelihood of developing thyroid eye disease by 7- to 8-fold, worsens disease severity, and significantly reduces treatment effectiveness.

Thyroid Dysfunction

Any abnormality in thyroid function—including hyperthyroidism, hypothyroidism, or unstable thyroid levels—can increase the risk of developing thyroid eye disease or worsening its progression.

Ocular Involvement and Symptom Progression

The symptoms of thyroid eye disease vary depending on the level of disease activity. They often progress in stages, although not all patients will experience every symptom.

Progression Early Active Phase Late Stable / Fibrotic Phase
Characteristics This stage is marked by active inflammation within the orbit, with symptoms progressing rapidly. Inflammatory activity has stabilized, but permanent structural changes or complications may remain.
Symptoms

Common symptoms include:

Dryness, light sensitivity, foreign-body sensation, conjunctival redness, eyelid redness and swelling, periorbital edema, mild double vision (overlapping images), eye pain, and color vision changes. Eyelid retraction may also appear during this phase, giving the eyes a "staring" appearance.

Severe symptoms may include:

Marked proptosis (eye bulging), which can lead to incomplete eyelid closure and result in excessive corneal exposure, dryness, epithelial defects, or even corneal ulceration. Enlargement of the extraocular muscles may restrict eye movement, causing persistent double vision (strabismus). The most serious complication is increased orbital pressure compressing the optic nerve, which may lead to decreased visual acuity, visual field loss, and in severe cases, permanent blindness. These changes in appearance can also impose significant psychosocial stress on patients.

Progression Early Active Phase
Characteristics This stage is marked by active inflammation within the orbit, with symptoms progressing rapidly.
Symptoms

Common symptoms include:

Dryness, light sensitivity, foreign-body sensation, conjunctival redness, eyelid redness and swelling, periorbital edema, mild double vision, eye pain, and color vision changes. Eyelid retraction may also appear during this phase, giving the eyes a "staring" appearance.

Progression Late Stable / Fibrotic Phase
Characteristics Inflammatory activity has stabilized, but permanent structural changes or complications may remain.
Symptoms

Severe symptoms may include:

Marked proptosis (eye bulging), which can lead to incomplete eyelid closure and result in excessive corneal exposure, dryness, epithelial defects, or even corneal ulceration. Enlargement of the extraocular muscles may restrict eye movement, causing persistent double vision (strabismus). The most serious complication is increased orbital pressure compressing the optic nerve, which may lead to decreased visual acuity, visual field loss, and in severe cases, permanent blindness. These changes in appearance can also impose significant psychosocial stress on patients.

Ideal Candidates for Orbital Decompression Surgery

  • Individuals with thyroid eye disease who experience eye protrusion that affects appearance or causes exposure-related ocular problems
  • Patients whose optic nerve is compressed due to thyroid eye disease, resulting in reduced visual acuity
  • Those with significant ocular discomfort, such as pain or pressure, that impacts daily quality of life
  • Patients who have inadequate response to conservative treatments such as corticosteroids or radiotherapy

Primary Treatment Methods

When medical treatments, such as corticosteroids, immunosuppressants, or biologic agents, or radiotherapy fail to adequately control disease progression, or when significant complications affecting vision or appearance have already developed, surgical intervention becomes essential. Orbital decompression surgery is the most critical surgical approach, aiming to create additional space for the compressed eyeball and optic nerve while simultaneously improving cosmetic appearance.

Orbital Decompression Surgery

Purpose

By removing portions of the orbital bone or orbital fat, the surgery enlarges the orbital space and reduces intraorbital pressure. This helps improve eye protrusion, relieve optic nerve compression, and lower intraocular pressure, while easing ocular discomfort. Beyond functional benefits, orbital decompression also plays a key role in restoring facial aesthetics.

Methods

Bony Decompression

Removal of selected portions of the orbital walls—such as the medial, inferior, lateral, or superior wall. This effectively increases orbital volume and allows the eye to shift inward or posteriorly.

Fat Decompression

Removal of excess orbital fat, particularly useful for patients whose disease is characterized primarily by fat proliferation.

Combined Decompression

A tailored approach that integrates both bony and fat decompression. The surgical plan is customized based on the patient's specific condition and orbital anatomy to achieve optimal functional and cosmetic outcomes.

Surgical Incisions

To minimize visible scarring, incisions are typically placed in discreet areas, such as through the conjunctiva, within natural eyelid creases, at the inner or outer canthus, or via minimally invasive endoscopic approaches. Postoperative scars are generally subtle and difficult to detect.

Other Related Procedures

(Corrective surgeries that may be performed after orbital decompression)

Strabismus Correction Surgery

Performed when fibrosis of the extraocular muscles results in persistent double vision. The procedure adjusts the position or tension of the extraocular muscles to correct ocular alignment.

Eyelid Correction Surgery

Used to address eyelid retraction, such as lowering the upper eyelid by adjusting the levator muscle or implanting tissue to restore a natural eyelid position.

Surgical Procedure Overview

01Preoperative Instructions

One Week Before Surgery:

・Discontinue anticoagulant medications (such as aspirin). Please confirm with your prescribing physician whether temporary discontinuation is appropriate.
・Stop taking all nutritional supplements (such as fish oil, ginkgo, ginseng, and vitamin E).
・Avoid smoking and alcohol from one week before surgery until one month after the procedure.

On the Day of Surgery:

・Please arrive with a clean face and no makeup; remove any eyelash extensions.
・Do not wear any accessories or metal items. If you have piercings, please remove them in advance.
・If you are nearsighted, you may wear contact lenses to the clinic, but they must be removed before surgery. Please bring a storage case, eyeglasses, or sunglasses for use afterward.

02Preoperative Surgical Planning
The surgeon will determine the degree of proptosis reduction that can be safely achieved based on your individual condition.
03Postoperative Care

Cold and Warm Compresses: Apply cold compresses as much as possible during the first 72 hours after surgery to help reduce swelling and discomfort.
Head Elevation: Keep your head elevated—such as by using extra pillows while sleeping—to promote lymphatic drainage and reduce swelling.
Eye Hygiene and Protection: Keep the eye area clean and avoid getting it wet to prevent infection.
Adequate Rest: Avoid strenuous activities that may increase pressure around the eyes, such as bending forward, lifting heavy objects, or forceful coughing or sneezing, to support proper healing.
Wound Care and Dressing Changes: Keep the incision area clean and dry after returning home, and change dressings as instructed. If skin sutures are present, they are typically removed around 6–10 days postoperatively, depending on wound condition.
How to Change Dressings: Clean the wound twice daily using sterile cotton swabs dipped in normal saline, dry the area, and then apply the prescribed ointment. When performing cold or warm compresses, place a piece of gauze over the wound to reduce the risk of infection.
Medication and Eye Hygiene: Use the prescribed eye drops or ointment as directed to prevent infection and support healing.
Eye Use and Daily Habits: Avoid prolonged use of mobile phones, computers, or looking down for extended periods. Allow your eyes sufficient rest to facilitate recovery.
Diet and Medications:

- You may take the prescribed pain relievers as needed to ease postoperative discomfort.
- Avoid irritants such as smoking, alcohol, tea, coffee, spicy foods, and dietary supplements (including vitamin E, lingzhi, and traditional herbal medicine).
- A light diet is recommended, along with adequate hydration and increased intake of protein and vitamin C to support wound healing.

04Follow-up Visits

Regular Monitoring: Close and regular follow-up appointments are required after surgery to evaluate intraocular pressure, visual acuity, eye position, and the recovery of ocular function. Additional corrective procedures may be planned based on postoperative progress and clinical needs.
Patience During Recovery: Swelling and bruising in the early postoperative period are normal. Final surgical outcomes and cosmetic improvements may take several weeks to several months to fully manifest. Patience is an essential part of the healing process.

Back to List

Appointment

TEL 02-2700-8069

Add Our Official LINE

2F, No. 263, Sec. 1, Dunhua S. Road,Da'an District, Taipei City 106, Taiwan

Monday ~ Friday
09:00 ~ 17:30
Saturday
09:00 ~ 13:30
Closed on
Sundays

Our clinic operates by appointment only.